Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia
Conditions
- Waldenstrom's Macroglobulinemia
Interventions
- DRUG: Ixazomib
- DRUG: Dexamethasone
- DRUG: Rituximab
Sponsor
Dana-Farber Cancer Institute
Collaborators